**Ultrasound Diagnosis of Chest Diseaseses**

Wei-Chih Liao, Chih-Yen Tu, Chuen-Ming Shih, Chia-Hung Chen, Hung-Jen Chen and Hsu Wu-Huei

Additional information is available at the end of the chapter

http://dx.doi.org/10.5772/55419

**1. Introduction**

Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medi‐

[177] Tang, A.M., et al., Simultaneous ultrasound and MRI system for breast biopsy: com‐ patibility assessment and demonstration in a dual modality phantom. IEEE transac‐

[178] Viallon, M., et al., Observation and correction of transient cavitation-induced PRFS thermometry artifacts during radiofrequency ablation, using simultaneous ultra‐

[179] Yatvin, M.B., et al., Design of liposomes for enhanced local release of drugs by hyper‐

[180] Lindner, L.H., et al., Novel temperature-sensitive liposomes with prolonged circula‐

[181] de Smet, M., et al., Magnetic resonance imaging of high intensity focused ultrasound mediated drug delivery from temperature-sensitive liposomes: an in vivo proof-of-

[182] Evjen, T.J., et al., Sonosensitive dioleoylphosphatidylethanolamine-containing lipo‐ somes with prolonged blood circulation time of doxorubicin. Eur J Pharm Sci, 2011.

[183] Hernot, S. and A.L. Klibanov, Microbubbles in ultrasound-triggered drug and gene

[184] Tinkov, S., et al., Microbubbles as ultrasound triggered drug carriers. J Pharm Sci,

[185] Ting, C.Y., et al., Concurrent blood-brain barrier opening and local drug delivery us‐ ing drug-carrying microbubbles and focused ultrasound for brain glioma treatment.

[186] Hynynen, K., Ultrasound for drug and gene delivery to the brain. Adv Drug Deliv

[187] Porter, T.R., et al., Thrombolytic enhancement with perfluorocarbon-exposed sonicat‐

[188] Molina, C.A., et al., Microbubble administration accelerates clot lysis during continu‐ ous 2-MHz ultrasound monitoring in stroke patients treated with intravenous tissue

ed dextrose albumin microbubbles. Am Heart J, 1996. 132(5): p. 964-8.

cine, 2010. 63(2): p. 290-6.

82 Advancements and Breakthroughs in Ultrasound Imaging

43(4): p. 318-24.

2009. 98(6): p. 1935-61.

Biomaterials, 2012. 33(2): p. 704-12.

Rev, 2008. 60(10): p. 1209-17.

tions on medical imaging, 2008. 27(2): p. 247-54.

thermia. Science, 1978. 202(4374): p. 1290-3.

tion time. Clin Cancer Res, 2004. 10(6): p. 2168-78.

concept study. J Control Release, 2011. 150(1): p. 102-10.

delivery. Adv Drug Deliv Rev, 2008. 60(10): p. 1153-66.

plasminogen activator. Stroke, 2006. 37(2): p. 425-9.

sound/MR imaging. Medical physics, 2010. 37(4): p. 1491-506.

Ultrasound (US) has been proved to be valuable for the evaluation of a wide variety of chest diseases, particularly when the pleural cavity is involved. The advantages of US are that it is a relatively inexpensive, widely available, mobile form of multi-planar imaging free from ionizing. Chest US can supplement other imaging modalities of the chest and guides a variety of diagnostic and therapeutic procedures. Under real-time US guidance the success rates of invasive procedures on pleural diseases increase significantly whereas the risks are greatly reduced. Chest US is a useful tool in the diagnosis of pleural diseases and peripheral pulmo‐ nary lesions. Moreover, endobronchial ultrasound (EBUS) is the real advance in recent chest medicine. This chapter will review the application of chest ultrasound and EBUS in chest medicine.
